Mitchell E. Hughes

503 total citations
31 papers, 284 citations indexed

About

Mitchell E. Hughes is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Mitchell E. Hughes has authored 31 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pathology and Forensic Medicine and 10 papers in Genetics. Recurrent topics in Mitchell E. Hughes's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (9 papers). Mitchell E. Hughes is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (9 papers). Mitchell E. Hughes collaborates with scholars based in United States. Mitchell E. Hughes's co-authors include Clyde M. Ofner, Sunita D. Nasta, Daniel J. Landsburg, Jakub Svoboda, Stephen J. Schuster, Noelle V. Frey, James N. Gerson, Craig W. Freyer, Elizabeth O. Hexner and David Porter and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Mitchell E. Hughes

29 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell E. Hughes United States 9 103 61 54 52 48 31 284
Drosos Tsavlis Greece 10 99 1.0× 42 0.7× 11 0.2× 66 1.3× 107 2.2× 32 443
Binhua Pan China 8 77 0.7× 142 2.3× 21 0.4× 43 0.8× 85 1.8× 23 496
Jamie H. VonRoenn United States 8 190 1.8× 33 0.5× 53 1.0× 102 2.0× 65 1.4× 10 402
Chan Hee Park South Korea 10 72 0.7× 22 0.4× 9 0.2× 71 1.4× 59 1.2× 29 308
Lozan Sheriff United Kingdom 8 53 0.5× 46 0.8× 9 0.2× 55 1.1× 106 2.2× 17 295
Lynne R. Eramo United States 8 74 0.7× 32 0.5× 38 0.7× 58 1.1× 73 1.5× 11 333
Yuji Amano Japan 10 89 0.9× 9 0.1× 17 0.3× 20 0.4× 70 1.5× 19 365
Kim Kj South Korea 9 47 0.5× 49 0.8× 56 1.0× 68 1.3× 67 1.4× 48 337
Vanessa Frangipane Italy 8 25 0.2× 29 0.5× 10 0.2× 26 0.5× 47 1.0× 14 213
Gaëlle Fossard France 7 52 0.5× 14 0.2× 18 0.3× 35 0.7× 41 0.9× 23 194

Countries citing papers authored by Mitchell E. Hughes

Since Specialization
Citations

This map shows the geographic impact of Mitchell E. Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Hughes more than expected).

Fields of papers citing papers by Mitchell E. Hughes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell E. Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Hughes. The network helps show where Mitchell E. Hughes may publish in the future.

Co-authorship network of co-authors of Mitchell E. Hughes

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell E. Hughes. A scholar is included among the top collaborators of Mitchell E. Hughes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell E. Hughes. Mitchell E. Hughes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hughes, Mitchell E., et al.. (2023). Remimazolam as an Adjunct to General Anesthesia During Spine Surgery in Adolescents. 13(1). 1–5. 2 indexed citations
2.
Hughes, Mitchell E., et al.. (2023). Remimazolam for Sedation During Fiberoptic Intubation in an Adolescent. Journal of Medical Cases. 14(8). 289–292. 6 indexed citations
3.
Landsburg, Daniel J., Sunita D. Nasta, Jakub Svoboda, et al.. (2023). Safety of CAR-T Cell Therapy in Asymptomatic Patients with Positive Respiratory Viral Testing Prior to CAR-T Infusions. Blood. 142(Supplement 1). 2341–2341. 1 indexed citations
4.
Svoboda, Jakub, Sunita D. Nasta, Stefan K. Barta, et al.. (2023). Combination of everolimus and itacitinib in patients with Hodgkin lymphoma relapsed/refractory to brentuximab vedotin (BV) and checkpoint inhibitors (CPI). Hematological Oncology. 41(S2). 594–595. 1 indexed citations
5.
Nasta, Sunita D., Mitchell E. Hughes, Alfred L. Garfall, et al.. (2022). Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting. Clinical Lymphoma Myeloma & Leukemia. 22(8). e730–e737. 11 indexed citations
6.
Ballard, Hatcher J., Austin R. Pantel, Mitchell E. Hughes, et al.. (2021). 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma. Molecular Imaging and Biology. 23(6). 818–826. 10 indexed citations
7.
Hughes, Mitchell E., Sunita D. Nasta, James N. Gerson, et al.. (2021). TIME‐TO‐RESPONSE FOR PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B CELL NON‐HODGKIN LYMPHOMA TREATED WITH POLATUZUMAB‐BASED THERAPY. Hematological Oncology. 39(S2). 1 indexed citations
8.
Freyer, Craig W., Alex Ganetsky, Mitchell E. Hughes, et al.. (2020). Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leukemia & lymphoma. 61(9). 2200–2207. 5 indexed citations
9.
Hughes, Mitchell E., Daniel J. Landsburg, Daniel J. Rubin, et al.. (2019). Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use. Clinical Lymphoma Myeloma & Leukemia. 19(12). 791–798. 9 indexed citations
10.
Hughes, Mitchell E., Stephen J. Schuster, Jakub Svoboda, et al.. (2019). REAL WORLD OUTCOMES OF OBINUTUZUMAB MONOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Hematological Oncology. 37(S2). 378–379.
11.
Ballard, Hatcher J., W. Tristram Arscott, Mitchell E. Hughes, et al.. (2019). Concurrent Use of Novel Agents and Radiation Is Tolerated in Lymphoma Patients. Blood. 134(Supplement_1). 2905–2905. 2 indexed citations
12.
Hughes, Mitchell E., et al.. (2019). Management and outcomes of sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman Disease). Leukemia & lymphoma. 61(4). 905–911. 7 indexed citations
13.
Svoboda, Jakub, Hatcher J. Ballard, Elise A. Chong, et al.. (2019). Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas. Blood. 134(Supplement_1). 1606–1606. 9 indexed citations
14.
Freyer, Craig W., Alex Ganetsky, Mitchell E. Hughes, et al.. (2018). Venous Thromboembolism Following Pegaspargase in Adults Receiving Antithrombin Supplementation: A Single Center Characterization of Risk Factors and an Assessment of Supplementation Practice. Blood. 132(Supplement 1). 4023–4023. 2 indexed citations
15.
Hughes, Mitchell E., et al.. (2018). Primer on Chronic Lymphocytic Leukemia: Part I. The Journal for Nurse Practitioners. 14(4). 302–308. 2 indexed citations
16.
Hughes, Mitchell E., et al.. (2018). Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis. Journal of the Advanced Practitioner in Oncology. 9(6). 614–629. 6 indexed citations
17.
Ganetsky, Alex, Jennifer Han, Mitchell E. Hughes, et al.. (2018). Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients. Clinical Infectious Diseases. 68(12). 2003–2009. 57 indexed citations
18.
Carver, Joseph R., Rupal O’Quinn, Suparna C. Clasen, et al.. (2017). Persistence of ibrutinib-associated hypertension in CLL pts treated in a real-world experience.. Journal of Clinical Oncology. 35(15_suppl). 7525–7525. 7 indexed citations
19.
Ganetsky, Alex, Jennifer Han, Mitchell E. Hughes, et al.. (2016). Oral Vancomycin Is Highly Effective in Preventing Clostridium Difficile infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Blood. 128(22). 2225–2225. 5 indexed citations
20.
Ganetsky, Alex, Todd A. Miano, Mitchell E. Hughes, et al.. (2015). Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients. Journal of Antimicrobial Chemotherapy. 70(7). 2078–2083. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Drosos Tsavlis Breakdown of academic impact, for papers by Binhua Pan Breakdown of academic impact, for papers by Jamie H. VonRoenn Breakdown of academic impact, for papers by Chan Hee Park Breakdown of academic impact, for papers by Lozan Sheriff Breakdown of academic impact, for papers by Lynne R. Eramo Breakdown of academic impact, for papers by Yuji Amano Breakdown of academic impact, for papers by Kim Kj Breakdown of academic impact, for papers by Vanessa Frangipane Breakdown of academic impact, for papers by Gaëlle Fossard
Rankless by CCL
2026